Who owns Synta Pharmaceuticals?

Key details on Synta Pharmaceuticals (Ticker: SNTA)

Who owns Synta Pharmaceuticals?

Is SNTA a good stock to own? Find out who bought Synta Pharmaceuticals, who sold Synta Pharmaceuticals (SNTA) stock, and who holds a large position in Synta Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
CAXTON 28.64M $123.44M March 31, 2014
Jennison Associates 6.54M $12.68M March 31, 2015
FMR 3.73M $7.23M March 31, 2015
BlackRock Fund Advisors 3.26M $6.33M March 31, 2015
Jefferies 3.24M $6.29M March 31, 2015
Vanguard 2.81M $5.46M March 31, 2015
Perceptive Advisors 2.38M $15.03M Sept. 30, 2013
S.A.C. Capital Advisors 2.01M $12.66M Sept. 30, 2013
JPMORGAN CHASE & CO 1.76M $9.22M Dec. 31, 2013
QVT Financial 1.75M $11.04M Sept. 30, 2013
Sectoral Asset Management 1.48M $11.30M Sept. 30, 2012
SUSQUEHANNA INTERNATIONAL 1.14M $3.43M Sept. 30, 2014
Ayer Capital Management 851635 $3.70M March 31, 2012
STATE STREET CORPORATION 790866 $1.53M March 31, 2015
Manatuck Hill Partners 784116 $6.74M March 31, 2013
NORTHERN TRUST 757686 $1.47M March 31, 2015
Ironwood Investment Management 738748 $1.43M March 31, 2015
GOLDMAN SACHS 731321 $3.15M March 31, 2014
BlackRock Institutional Trust Company, N.A. 728347 $1.41M March 31, 2015
Millennium Management 717510 $1.90M Dec. 31, 2014
Driehaus Capital Management 713498 $6.14M March 31, 2013
D. E. Shaw & Co 687566 $2.07M Sept. 30, 2014
Renaissance Technologies 656700 $1.27M March 31, 2015
Deutsche Bank Aktiengesellschaft 652298 $3.42M Dec. 31, 2013
MORGAN STANLEY 630445 $1.67M Dec. 31, 2014
Hambrecht & Quist Capital Management 625000 $3.42M June 30, 2012
Oxford Asset Management 601896 $3.80M Sept. 30, 2013
Barclays 560371 $3.31M Sept. 30, 2013
Scoggin 559000 $4.81M March 31, 2013
Balyasny Asset Management 541120 $4.88M Dec. 31, 2012
Geode Capital Management 509162 $987774 March 31, 2015
Baker Bros. Advisors 500000 $1.32M Dec. 31, 2014